Genlink Pharma Solutions Private Limited - Due diligence report

A 360° intelligence report on Genlink Pharma Solutions: trust score, financial health, credit view, compliance, directors, growth and distre…

2016-05-06 Thane, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
GP Genlink Pharma Solutions Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genlink Pharma Solutions — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Genlink Pharma Solutions is assessed as Low Risk with a Trust Score of 83/100. Genlink Pharma Solutions is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 31 Jul 2026 from the latest processed filings. Genlink Pharma Solutions Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 3 satisfied (52.41 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 auditor resignation(s) filed - latest: PRASHANT MOLIYA on 2017-09-11.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
AVANI ANAND SHAH 01234567 Director 01/04/2018 6 yrs Approved
ANAND PRAFULCHANDRA SHAH 01234567 Director 01/04/2018 6 yrs Approved
Chaitali Jayant Gawkar 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Enaltec Labs Private Limited Associate Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Operating for 10+ years.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
1 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
08 Apr 2025
Charge satisfied
Others
31 Mar 2025
Latest balance sheet
Filed with ROC
03 Feb 2025
Charge satisfied
Others
06 Nov 2024
Director ceased
SUMIT GUPTA
08 Apr 2024
Charge satisfied
Axis Bank Limited
11 Dec 2023
Director appointed
Chaitali Jayant Gawkar (Company Secretary)
23 May 2022
Director ceased
ANAND PRAFULCHANDRA SHAH
04 Nov 2020
Director ceased
GANESHPRASAD AMRUTLAL GUPTA
30 Sep 2019
Director ceased
AVANI ANAND SHAH
16 May 2019
Charge created
Others - 24.50 cr
15 Jan 2019
Director appointed
AVANI ANAND SHAH (Director)
16 Nov 2018
Charge created
Axis Bank Limited - 2.91 cr
30 Oct 2017
Director ceased
SUSHEEL KOUL
27 Mar 2017
Securities allotted
250 Debentures - 25.00 cr raised
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Greatvalue Homz Private Limited U70101DL2010PTC207465 New Delhi, Delhi, India
Rawdon Apartments Private Limited U70101WB1997PTC085062 Kolkata, West Bengal, India
Eta Greens Buildtech Private Limited U45200DL2007PTC160664 New Delhi, Delhi, India
Star And Style Furnitures Private Limited U22210MH1996PTC097445 Navi Mumbai, Maharashtra, India
Jayadarsini Housing Private Limited U70102TG1996PTC022754 Seri Lingampally, Telangana, India
Ashu Engineers And Plastics Private Limited U29100MH1979PTC022048 Mumbai, Maharashtra, India
Shanker Twine Products Private Limited U17232DL2005PTC133029 New Delhi, Delhi, India
Shree Binayak Infradevelopers Private Limited U45200DL2008PTC185612 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genlink Pharma Solutions before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genlink Pharma Solutions: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Genlink Pharma Solutions - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Genlink Pharma Solutions pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genlink Pharma Solutions - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genlink Pharma Solutions an active company?

Genlink Pharma Solutions has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Genlink Pharma Solutions financially healthy?

Genlink Pharma Solutions has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Genlink Pharma Solutions?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genlink Pharma Solutions?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Genlink Pharma Solutions have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Genlink Pharma Solutions up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Genlink Pharma Solutions?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.